Journal Information
Vol. 7. Issue 34.
Pages 41-45 (January - February 1993)
Vol. 7. Issue 34.
Pages 41-45 (January - February 1993)
Open Access
Controlling the HIV Epidemic Among Drug Injectors
Visits
3508
Samuel R. Friedman, Don C. Des Jarlais
National Development and Research Institutes. Inc, New York
This item has received
Article information
Full text is only aviable in PDF
Bibliografía
[1.]
Fuente L, Barrio G, Izquierdo M, et al. Changes in risky practices of patients with cocaine and/or opiate dependence after knowing their HIV infection status: a national study (Spain). Sixth International Conference on AIDS, San Francisco, 1990 (Poster #FC110).
[2.]
Merino F, Aizpiri J, Esparza J, et al. HIV-1 infection in a drug control center in the Basque country, Northern Spain, 1984–1989. Sixth International Conference on AIDS, San Francisco, 1990 (Poster #FC644).
[3.]
P. Sopelana, A. Diéguez, L. Bautista.
Prevalencia de la infección por el virus de la inmunodeficiencia humana tipo 1 en drogodependientes de Madrid, durante un período de 5 años.
Med Clin (Barc), 97 (1991), pp. 601-603
[4.]
S.R. Friedman, D.C. Des Jarlais.
HIV among drug injectors: the epidemic and the response.
AIDS Care, 3 (1991), pp. 239-250
[5.]
S.R. Friedman.
The social structuring of personal risk behavior (Presented at I Congreso Nacional sobre el SIDA, Madrid).
SIDA, 2 (1991), pp. 167-168
[6.]
Friedman SR, Nealgus A. Respuestas conductuales y sociales de los toxicómanos que se inyectan ante la amenaza del SIDA. En: Proceedings of the Congreso Internacional sobre la problemática social del SIDA, Bilbao, 1990: 131–46.
[7.]
D.C. Des Jarlais, K. Choopanya, J. Wenston, et al.
Risk reduction and stabilization of seroprevalence among drug injectors in New York City and Bangkok, Thailand.
Science challenging AIDS: Proceedings of the VII International Conference on AIDS. Florence, pp. 207-213
[8.]
Lima ES, Friedman SR, Bastos FI, et al. Risk factors for HIV-l seroprevalence among drug injectors in the cocaine using environment of Rio de Janeiro (en prensa).
[9.]
P.R. Teiles, F.l. Bastos, E.S. Lima, et al.
HIV-1 epidemiology among IDUs in Rio de Janeiro, Brazil.
Eighth International Conference on AIDS, ¿, (1992),
[10.]
D.C. Des Jarlais, S.R. Friedman.
The AIDS epidemic and legal access to sterile equipment for injecting illicit drugs.
Ann Am Acad Poli & Soc Sci, 521 (1992), pp. 42-65
[11.]
H. Hagan, D.C. Des Jarlais, D. Purchase, et al.
The incience of HBV infection and syringe exchange programs (Letter).
JAMA, 266 (1991), pp. 1646-1647
[12.]
H. Hagan, D.C. Des Jarlais, D. Purchase, et al.
Lower HIV seroprevalence, declining HBV incidence and safer injection in relation to the Tacoma syringe exchange.
Seventh International Conference on AIDS, ¿, (1991),
[13.]
K. Kali, R. Olin.
HIV status and changes in risk behavior among intravenous drug users in Stockholm 1987–88.
AIDS, 4 (1990), pp. 153-157
[14.]
B. Ljungberg, B. Christensson, K. Tunving, et al.
HIV prevention among injecting drug users: three years of experience fro m a syringe exchange program in Sweden.
JAIDS, 4 (1991), pp. 890-895
[16.]
H.J.A. van Haastrecht, J.A.R. van den Hoek, C. Bardoux, et al.
The course of the HIV epidemic among intravenous drug users in Amsterdam, the Netherlands.
Am J Public Health, 81 (1991), pp. 59-62
[17.]
New York City Department of health.
The Pilot needle exchange study in New York City: a bridge to treatment: a report on the first ten months of operation.
NYC Department of Health, (1989),
[18.]
P. Espinoza, I. Bouchard, P. Ballian, J. Polo Devoto.
Has the open sale of syringes modified the syringe exchanging habits of drug addicts?.
Fourth International Conferente on AIDS, (1988),
[19.]
F.R. Ingold, J. Ingold.
The effects of the liberalization of syringe sales on the behaviour of intravenous drug users in France.
Bull on Narc, 41 (1989), pp. 67-81
[20.]
Friedman SR, de Jong W, Wodak A. Community developmenl as a response to HIV among drug injectors. AIDS 92/93 (supplement) (en prensa)
[21.]
DL. Higgins, C. Galavotti, K.R. O'Reilly, et al.
Evidencefor the effects of HIV antibody counseling and testing on risk behaviors.
JAMA, 266 (1991), pp. 2418-2429
[22.]
L. Solomon, R. Frank, D. Vlahov, et al.
Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus.
Am J Public Health, 81 (1991), pp. 1285-1290
[23.]
I.B. Weisfuse, D. Temu, P.A. Thomas.
Prophylactic drug use among New York City AIDS patients.
Eighth International Conference on AIDS, ¿, (1992),
[24.]
S.R. Friedman, D.C. Des Jarlais, A. Nealgus.
AIDS among drug injectors: the first decade.
AIDS: etiology, diagnosis, treatment and prevention, 3rd edition, pp. 453-461
[25.]
G. Medley, K.A. Dolan, G.V. Stimson.
A model of HIV transmission by syringe sharing in English prisons using surveys of injecting drugs users.
Eighth International Conference on AIDS, ¿, (1992),
[26.]
T. Hammett, T.W. Harding, S. Egger, et al.
The policy response to HIV in prisons worldwide.
Eighth International Conference on AIDS, ¿, (1992),
Copyright © 1993. Sociedad Española de Salud Pública y Administración Sanitaria